Needham Raises its Price Target on Globus Medical (GMED)

On May 8, 2026, Needham raised the firm’s terms people connected Globus Medical, Inc. (NYSE:GMED) to $117 from $114 portion maintaining a Buy standing connected the shares.

Meanwhile, Wells Fargo expert Larry Biegelsen lowered the firm’s terms people connected Globus Medical, Inc. (NYSE:GMED) to $103 from $104 portion maintaining an Overweight standing connected the shares. The steadfast noted that Globus Medical delivered Q1 gross and EPS up of some its ain estimates and broader statement expectations.

Globus Medical, Inc. (NYSE:GMED) reported Q1 EPS of $1.12, versus the statement estimation of 92c. Revenue totaled $759.85M, compared to the statement estimation of $740.83M. President and CEO Keith Pfeil said the institution began 2026 with beardown momentum, highlighted by 27% wide gross maturation and grounds first-quarter earnings. Organic gross accrued much than 13%, supported by marketplace stock gains and beardown procedural volumes successful the halfway spine business, portion the Enabling Technologies conception continued expanding its lawsuit base. Pfeil added that manufacturing and proviso concatenation execution, structural outgo actions, and operating leverage from higher volumes contributed to borderline enlargement that outpaced gross growth. The institution said its strategical absorption remains centered connected improving surgical outcomes done an integrated ecosystem that combines diligent selection, surgical techniques, implants, and enabling technologies.

Globus Medical besides raised its FY26 EPS outlook to $4.70-$4.80 from a anterior scope of $4.40-$4.50. Consensus estimates were $4.47. The institution reaffirmed its FY26 gross guidance of $3.18B-$3.22B, compared to statement expectations of $3.2B.

Globus Medical, Inc. (NYSE:GMED) develops and commercializes musculoskeletal healthcare solutions and surgical technologies successful the United States and planetary markets.

While we admit the imaginable of GMED arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.